HOOKIPA Pharma Inc.
HOOK · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $44 | $20 | $14 | $18 |
| % Growth | 118.3% | 41.3% | -22.8% | – |
| Cost of Goods Sold | $3 | $4 | $4 | $5 |
| Gross Profit | $41 | $17 | $11 | $14 |
| % Margin | 93.7% | 82.4% | 74.7% | 74.8% |
| R&D Expenses | $69 | $86 | $69 | $83 |
| G&A Expenses | $20 | $19 | $19 | $17 |
| SG&A Expenses | $20 | $19 | $19 | $19 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $2 |
| Other Operating Expenses | -$60 | $13 | -$4 | -$7 |
| Operating Expenses | $28 | $118 | $84 | $95 |
| Operating Income | -$51 | -$98 | -$73 | -$82 |
| % Margin | -117.1% | -485.3% | -513.4% | -442.7% |
| Other Income/Exp. Net | $8 | $16 | $8 | $6 |
| Pre-Tax Income | -$44 | -$81 | -$65 | -$76 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$44 | -$82 | -$65 | -$76 |
| % Margin | -99% | -405.3% | -455.6% | -410.2% |
| EPS | -3.47 | -8.63 | -9.91 | -23.04 |
| % Growth | 59.8% | 12.9% | 57% | – |
| EPS Diluted | -3.47 | -8.63 | -9.91 | -23.04 |
| Weighted Avg Shares Out | 13 | 9 | 7 | 3 |
| Weighted Avg Shares Out Dil | 13 | 9 | 7 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $5 | $2 | $0 |
| Interest Expense | $0 | $0 | $1 | $1 |
| Depreciation & Amortization | $3 | $4 | $4 | $5 |
| EBITDA | -$41 | -$77 | -$60 | -$70 |
| % Margin | -93% | -384.2% | -423.9% | -380.1% |